✦ LIBER ✦

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

✍ Scribed by Antonio Daponte, Simona Signoriello, Luigi Maiorino…

Book ID: 120690364
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 445 KB
Volume: 11
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-11-38

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, dacarbazine, and fotemustine

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

Combined treatment with pegylated interf

Combined treatment with pegylated interferon–α-2a and dacarbazine in patients with advanced metastatic melanoma : A phase 2 study

✍ Axel Hauschild; Reinhard Dummer; Selma Ugurel; Katharina C. Kaehler; Friederike 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

A phase II study of combined administrat

A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-α2a in patients with advanced malignant melanoma

✍ Han G. Ron; Yair Mordish; Avi Eisenthal; Yehuda Skornick; Moshe J. Inbar; Samari 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

7004 ORAL Phase II randomized, placebo c

7004 ORAL Phase II randomized, placebo controlled study of sorafenib in combination with dacarbazine in subjects with unresectable Stage III or Stage IV melanoma

✍ McDermott, D.; Sosman, J.A.; Hodi, F.S.; Gonzalez, R.; Linette, G.; Richards, J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase II study of vindesine and dacarbaz

Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanoma

✍ Verschraegen, C.F.; Legha, S.S.; Hersh, E.M.; Plager, C.; Papadopoulos, N.; Burg 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 424 KB